Mission Street and BentallGreenOak have commenced delivery of a new 100,000 sq ft life sciences facility in the Cambridge Southern Cluster.
The joint venture partners are transforming a 7.8-acre site in Foxton, which used to be home to a printworks, into a state-of-the-art new build facility called The Press.
Phase one consists of 16,000 sq ft of fully-fitted lab and office space across two refurbished units, which will be completed in Q3 this year. Phase two will see the delivery of a new 65,000 sq ft building, due to complete in summer 2024.
Artem Korolev, founder and CEO of Mission Street, said: “As part of our plans for The Press, we are bringing much-needed purpose-built life science space online quickly into market that is suffering from an acute shortage of stock. Britain’s life sciences sector is at an inflection point, and to fully realise the potential of our world-leading research and discovery, we must focus on providing the facilities that will enable our burgeoning R&D ecosystem to scale and commercialise.
“Our plans for The Press have been developed through extensive and overwhelmingly positive engagement with the local community and key stakeholders. We now look forward to delivering a design-led scheme that will be an attractive addition to the Cambridge ecosystem, and continuing to engage with some incredibly exciting occupiers in supporting their growth.”
